Search documents
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
Yahoo Finance· 2026-03-31 16:28
Drugmaker Agios Pharmaceuticals (NASDAQ: AGIO) is positioning to win the FDA's approval of its mitapivat as a treatment for sickle cell disease sooner than investors may have been expecting. That's the overarching takeaway from this morning's press release anyway. As it explains, Agios' recent meeting with the U.S. Food and Drug Administration laid the groundwork for the "submission of a proposal for a confirmatory clinical trial to support U.S. accelerated approval of mitapivat." The company's already su ...
Worried About the Stock Market in 2026? Here's What Retirement Savers Need to Know.
Yahoo Finance· 2026-03-31 16:28
If stock market events over the past few weeks have left you feeling uneasy, you're not alone. Ever since the Iran conflict erupted, markets have been volatile. But if they cause your retirement savings to take a beating on screen, it can be very concerning. Before you make any drastic moves, though, it's important to take a step back and recognize that your nest egg may not be in danger the way you might think it is. Will AI create the world's first trillionaire? Our team just released a report on the on ...
Dollar Is Tracking Its Best Quarter Since 2024
Barrons· 2026-03-31 16:28
The dollar's role as a safe haven triggered the rally after the Iran conflict broke out on Feb. 28. ...
Apple tests Siri feature that handles multiple commands at once, Bloomberg News reports
Reuters· 2026-03-31 16:27
Apple tests Siri feature that handles multiple commands at once, Bloomberg News reports | Reuters Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Apple did not immediately respond to a Reuters' request for comment. Apple logo is seen in this illustration taken September 24, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab March 31 (Reuters) - Apple (AAPL.O), opens new tabis testing a feature that would let Siri process m ...
Uber increases stake in WeRide as robotaxi partnership ramps up in Dubai
TechCrunch· 2026-03-31 16:26
Uber and Chinese autonomous vehicle company WeRide have launched robotaxi operations without a human safety operator in Dubai as part of a broader expansion in the Middle East.Riders can now book the vehicles through Uber’s app, with operations in commercial and industrial districts like Dubai Silicon Oasis, Dubai Investment Park Second, and Jabal Ali Industrial First, as well as suburban areas and the maritime trading hub Al Hamriya Port. The service is operated locally by Tawasul, a mobility and fleet ope ...
Jones Lang LaSalle: Eyes On Growth And Valuations
Seeking Alpha· 2026-03-31 16:25
Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e., buying assets at a discount, e.g., net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e., buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get st ...
Master Investor Ray Dalio's Strategy Shows Up in This ETF -- And It Could Help You Invest More Confidently
Yahoo Finance· 2026-03-31 16:25
It's only when markets are choppy that investors find out what their real risk tolerance is. It's easy to fill out a questionnaire and say you'd be able to withstand a correction or bear market, but it's another thing entirely to actually see 10%, 20%, or more of your portfolio wiped out -- often more quickly than you'd expect. If you're finding that you're less tolerant of risk than you expected in the downturn over the past month, then the concept of an "all-weather portfolio" might appeal to you. One ...
Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs
Invezz· 2026-03-31 16:24
Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, marking a significant expansion of the drugmaker's neuroscience portfolio into sleep medicine. Under th... ...
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
Yahoo Finance· 2026-03-31 16:23
The company’s business model centers on the discovery, development, and commercialization of innovative medicines for rare hematologic diseases.Agios Pharmaceuticals develops and commercializes therapeutics targeting cellular metabolism, with its lead product, PYRUKYND (mitapivat), for hemolytic anemias, and AG-946 in Phase I clinical trials.How does this trade relate to historical activity? Krishnan joined Agios on March 5, 2025, making this transaction his one-year employment anniversary and the first ves ...
Banco De Chile: Leading Profitability And Capital Strength In Chile's Banking Sector
Seeking Alpha· 2026-03-31 16:23
Banco de Chile ( BCH ) has a forward non-GAAP price-to-earnings multiple of 13.39x, which represents excellent value compared to Banco Santander-Chile's and Bradesco's multiples of 11.59x and 6.95x, respectively. BCH also benefits from being the leading bank in Chile's concentrated bankingI'm DCF Value Investor a passionate individual analyst with unique ideas that cover all types of stocks and commodities. I focus on companies fundamentals and valuation, to deliver a proper investment analysis. My ideas ex ...